137 results
Page 3 of 7
8-K
EX-10.1
r333fgd2nutp0j73
25 Jun 21
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-10.1
a3qr5xraqqeyjw0 2558
21 Jun 21
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-1.1
38hne0 nym0ol4gp
4 Feb 21
Moleculin Announces Proposed Underwritten Public Offering
4:07pm
424B5
ec60bh2qhv8n 14f68f
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
se5l 94a4
2 Feb 21
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
kkp3dj9n 17g
29 Dec 20
Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
7:29am
424B5
mj0lj6a4h669tt9p0w
12 Nov 20
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
m3h0214v71 jb
29 Oct 20
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
7:29am
S-8
EX-4.4
2j4i l8nkw2h7xon9zsy
21 Aug 20
Registration of securities for employees
4:31pm
8-K
EX-99.1
x3xg4j2jl1jzss11
12 Aug 20
Results of Operations and Financial Condition
7:32am